Search Results | Diabetes Care | American Diabetes Association

1-20 of 67

2 3 4

Sort by

Sort Order Select

Journal Articles

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Jelle M. Beernink, Frederik Persson, Niels Jongs, Gozewijn D. Laverman, Glenn M. Chertow, John J.V. McMurray, Anna Maria Langkilde, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink

Diabetes Care dc221514

DOI: https://doi.org/10.2337/dc22-1514

Published: 20 January 2023

View article

Journal Articles

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Viktor Rotbain Curovic, Niels Jongs, Marjolein Y.A.M. Kroonen, Emilie H. Zobel, Tine W. Hansen, Taha Sen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink

Diabetes Care dc221699

DOI: https://doi.org/10.2337/dc22-1699

Published: 18 January 2023

View article

Journal Articles

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Ian H. de Boer, Kamlesh Khunti, Tami Sadusky, Katherine R. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, Peter Rossing, George Bakris

Diabetes Care 2022;45(12):3075–3090

DOI: https://doi.org/10.2337/dci22-0027

Published: 03 October 2022

View article

Journal Articles

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, Robert A. Gabbay, Jennifer Green, Nisa M. Maruthur, Sylvia E. Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Tsvetalina Tankova, Apostolos Tsapas, John B. Buse

Diabetes Care 2022;45(11):2753–2786

DOI: https://doi.org/10.2337/dci22-0034

Published: 28 September 2022

View article

Journal Articles

Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial

Jonas Askø Andersen, Anne Rasmussen, Susanne Engberg, Jesper Bencke, Marie Frimodt-Møller, Klaus Kirketerp-Møller, Peter Rossing

Diabetes Care 2022;45(11):2492–2500

DOI: https://doi.org/10.2337/dc22-0085

Published: 24 September 2022

View article

Journal Articles

Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

Ninna Hahn Tougaard, Alexandra Louise Møller, Pernille Falberg Rønn, Tine Willum Hansen, Federica Genovese, Morten Asser Karsdal, Daniel Guldager Kring Rasmussen, Peter Rossing

Diabetes Care 2022;45(11):2746–2748

DOI: https://doi.org/10.2337/dc22-0852

Published: 12 September 2022

View article

Journal Articles

Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

Viktor Rotbain Curovic, Mie Klessen Eickhoff, Teemu Rönkkö, Marie Frimodt-Møller, Tine Willum Hansen, Harald Mischak, Peter Rossing, Tarunveer Singh Ahluwalia, Frederik Persson

Diabetes Care 2022;45(11):2662–2668

DOI: https://doi.org/10.2337/dc22-1157

Published: 23 August 2022

View article

Journal Articles

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal, on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators

Diabetes Care 2022;45(12):2991–2998

DOI: https://doi.org/10.2337/dc22-0294

Published: 15 August 2022

View article

Journal Articles

Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes

Diabetes Care 2022;45(6):1416–1427

DOI: https://doi.org/10.2337/dc21-2204

Published: 04 April 2022

View article

Journal Articles

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA_1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Pieter Gillard, Richard J. MacIsaac, Julio Wainstein, Amer Joseph, Meike Brinker, Lothar Roessig, Charlie Scott, George L. Bakris

Diabetes Care 2022;45(4):888–897

DOI: https://doi.org/10.2337/dc21-1944

Published: 21 January 2022

View article

Journal Articles

Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

Diabetes Care 2021;44(9):2098–2106

DOI: https://doi.org/10.2337/dc21-0737

Published: 08 July 2021

View article

Journal Articles

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

Frederik Persson, Peter Rossing, Priya Vart, Glenn M. Chertow, Fan Fan Hou, Niels Jongs, John J.V. McMurray, Ricardo Correa-Rotter, Harpreet S. Bajaj, Bergur V. Stefansson, Robert D. Toto, Anna Maria Langkilde, David C. Wheeler, Hiddo J.L. Heerspink

Diabetes Care 2021;44(8):1894–1897

DOI: https://doi.org/10.2337/dc21-0300

Published: 28 June 2021

View article

Journal Articles

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907

Dorte Vistisen, Gregers S. Andersen, Adam Hulman, Stuart J. McGurnaghan, Helen M. Colhoun, Jan E. Henriksen, Reimar W. Thomsen, Frederik Persson, Peter Rossing, Marit E. Jørgensen

Diabetes Care 2021;44(6):e140–e141

DOI: https://doi.org/10.2337/dci21-0010

Published: 18 June 2021

View article

Journal Articles

A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

Dorte Vistisen, Gregers S. Andersen, Adam Hulman, Stuart J. McGurnaghan, Helen M. Colhoun, Jan E. Henriksen, Reimar W. Thomsen, Frederik Persson, Peter Rossing, Marit E. Jørgensen

Diabetes Care 2021;44(4):901–907

DOI: https://doi.org/10.2337/dc20-2586

Published: 28 January 2021

View article

Journal Articles

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Frederik Persson, Stephen C. Bain, Ofri Mosenzon, Hiddo J.L. Heerspink, Johannes F.E. Mann, Richard Pratley, Itamar Raz, Thomas Idorn, Søren Rasmussen, Bernt Johan von Scholten, Peter Rossing

Diabetes Care 2021;44(4):1020–1026

DOI: https://doi.org/10.2337/dc20-1622

Published: 27 January 2021

View article

Journal Articles

Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Nete Tofte, Simone Theilade, Signe A. Winther, Sørine Birkelund, Jens P. Goetze, Tine W. Hansen, Peter Rossing

Diabetes Care 2021;44(2):595–603

DOI: https://doi.org/10.2337/dc20-2107

Published: 15 December 2020

View article

Journal Articles

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes

Ajenthen G. Ranjan, Signe V. Rosenlund, Tine W. Hansen, Peter Rossing, Steen Andersen, Kirsten Nørgaard

Diabetes Care 2020;43(11):2882–2885

DOI: https://doi.org/10.2337/dc20-0909

Published: 04 September 2020

View article

Journal Articles

Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43: 487–493

John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A. D’Alessio, Melanie J. Davies

Diabetes Care 2020;43(7):1670

DOI: https://doi.org/10.2337/dc20-er07

Published: 11 June 2020

View article

Journal Articles

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

John B. Buse, Deborah J. Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A. D’Alessio, Melanie J. Davies

Diabetes Care 2020;43(2):487–493

DOI: https://doi.org/10.2337/dci19-0066

Published: 19 December 2019

View article

Journal Articles

Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Sascha Pilemann-Lyberg, Tine Willum Hansen, Peter Rossing

Diabetes Care 2019;42(12):e188

DOI: https://doi.org/10.2337/dci19-0037

Published: 12 November 2019

View article

2 3 4

NARROW

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial

Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA_1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907

A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes

Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43: 487–493

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only